Search Results
Jan 22, 2026, 18:54 ET Genomics pioneer J. Craig Venter launches Diploid Genomics, Inc. (DGI), ushering in a new era in human genomics
know-how and expertise from JCVI, and is helmed by Dr. Venter, along with multimodal imaging expert Anders Dale, Ph.D., and computational sciences expert Gene Myers, Ph.D.Dr. Venter is JCVI founder and founder of its precursor organization, The Institute for Genomic Research (TIGR) where he and his
More news about: J. Craig Venter Institute
Jan 22, 2026, 13:51 ET Lovet Pet Health Care℠ Wins Two VETTY Awards® for Excellence in Animal Health Care Marketing
in marketing animal health care products, programs and services."The VETTY Awards honors the storytellers of animal healthcare," said NAVC CEO Gene O'Neill. "These talented marketing and communications teams have an innate ability to create content that resonates with both veterinary professionals
More news about: Lovet Pet Health Care
Jan 22, 2026, 11:12 ET Replacing Microbiota Makes Aging Intestines Young Again
demonstrated that aging results in changes to the mix of commensal (or helpful) microbiota in the gut. This specifically reduced key signaling involving the gene Ascl2 and WNT signaling among the intestinal stem cells (ISCs) within the intestine lining."This reduced signaling causes a decline in
More news about: Cincinnati Children's Hospital Medical Center
Jan 22, 2026, 10:16 ET 'Functional Unemployment' Hits Highest Level Since 2021, Says Ludwig Institute
@LISEP_org.About Gene LudwigIn addition to his role as LISEP chair, Gene Ludwig is a managing partner of Canapi LLC, a financial technology venture fund. He is the founder and CEO of Ludwig
More news about: Ludwig Institute for Shared Economic Prosperity
Jan 22, 2026, 09:37 ET Insilico Medicine Launches Science MMAI Gym to Transform Frontier LLMs into Pharmaceutical-Grade Scientific Engines
reaction reasoning, retrosynthesis, and 3D structure-property relationships.Biology and target discovery: Omics-aware reasoning over gene expression, pathways, disease mechanisms, and multi-objective target scoring.Clinical development: Interpretation of trial designs,
More news about: Insilico Medicine
Jan 22, 2026, 08:30 ET Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of Grant to Address Immunotherapy Resistance in Melanoma
mechanisms of tumor resistance, and optimizing TIL selection and expansion to improve therapeutic outcomes.Dr. Madi and his team are studying the gene circuits that program immune cells, controlling their differentiation, activation, and regulation. By examining how T cells behave in tumors, particularly
More news about: Israel Cancer Research Fund
Jan 22, 2026, 07:40 ET Hansa Biopharma has won the 2025 SwedenBIO Award
or complex immune disorders. Hansa's proprietary IgG-cleaving enzyme technology platform to address serious unmet medical needs in transplantation, gene therapy and autoimmune diseases. The company's portfolio includes imlifidase, a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy,
More news about: Hansa Biopharma AB
Jan 22, 2026, 07:38 ET Hansa Biopharma has won the 2025 SwedenBIO Award
or complex immune disorders. Hansa's proprietary IgG-cleaving enzyme technology platform to address serious unmet medical needs in transplantation, gene therapy and autoimmune diseases. The company's portfolio includes imlifidase, a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy,
More news about: Hansa Biopharma AB
Jan 22, 2026, 05:00 ET Pilot Study Finds 30-Day Molecular Improvement in Prostate Health Following Intraprostatic Ozone Therapy, Tracked by the EpiSwitch® PSE Blood Test
patients repeated PSA and PSE testing. Marker-level patterns included directional changes in regions associated with extracellular matrix remodeling and gene regulation, aligning with the overall PSE score reductions."We observed coordinated molecular shifts over a short interval in most participants,
More news about: Forum Health, LLC
Jan 22, 2026, 04:00 ET Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
India. "The policy prioritizes frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities. It strengthens the broader ecosystem across clinical research,
More news about: Telengana Life Sciences Foundation
Jan 21, 2026, 22:30 ET Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
India. "The policy prioritizes frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities. It strengthens the broader ecosystem across clinical research,
More news about: Telengana Life Sciences Foundation
Jan 21, 2026, 17:31 ET Cystinosis Market to Grow at a Substantial Growth Rate of 5.1% During the Forecast Period (2025-2034) | DelveInsight
highlight a shift toward enhanced systemic cystine control and potential disease modification, including strategies that improve cysteamine delivery and gene-based correction of the underlying CTNS defect.LAS VEGAS, Jan. 21,
More news about: DelveInsight Business Research, LLP
Jan 21, 2026, 13:02 ET Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
India. "The policy prioritizes frontier science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation, and other next-generation modalities. It strengthens the broader ecosystem across clinical research,
More news about: Telengana Life Sciences Foundation
Jan 21, 2026, 10:08 ET Jeffrey Modell Foundation Awards $550,000 to Innovative Primary Immunodeficiency Research
Fondazione Telethon ETS (Rome, Italy) for a project titled "In Vivo Gene Therapy for ADA-SCID" ($250,000)Dr. Daniella Schwartz,
More news about: Jeffrey Modell Foundation
Jan 21, 2026, 10:00 ET Mothers Against Drunk Driving Announces Three New National Board Members to Help Lead Lifesaving Mission
accelerate the lifesaving impact of MADD."Gene Boehm is the President & CEO of AAA, Inc., a federation of 19 auto clubs serving more than 58 million members across the United States. Known for his collaborative, people-first leadership style, Gene has worked across mobility, insurance, and transportation
More news about: Mothers Against Drunk Driving (MADD)
Jan 21, 2026, 08:00 ET Pangea Laboratory and Gene Solutions Establish Strategic Collaboration to Advance Cancer Diagnostics in the United States
integrated validation platform and regulatory expertise to oversee all analytical and clinical validation activities for Gene Solutions' innovative multi-omics technologies. Gene Solutions will provide standard operating procedures, funding, and technical support from its CAP-accredited laboratories
More news about: Pangea Laboratory
Jan 21, 2026, 02:20 ET Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
diversified client needs. Bio Campus III is expected to support expanded capabilities across advanced conjugation technologies, as well as cell and gene therapies and antibody vaccines. Under its optimized manufacturing framework, ExellenS™, Samsung Biologics continued to invest in operational
More news about: Samsung Biologics
Jan 20, 2026, 13:53 ET Olatec Therapeutics Presented Preclinical Evidence of Disease-Modifying Activity with Dapansutrile in its Parkinson's Studies
neurons in the substantia nigra and striatumReduced α-synuclein pathology and intracellular accumulationReversed pathogenic microglial gene-expression signatures, normalizing ~75% of upregulated genes (including Lrrk2) and counteracting the disease-associated microglial phenotype identified
More news about: Olatec Therapeutics, Inc.
Jan 20, 2026, 12:39 ET LIVE FROM VMX 2026: Innovation, Energy and Breakthrough Diagnostics Take Over Orlando
his dog, Peanut, and thanked veterinarians "for injecting life into care with kindness," setting a tone of passion and purpose for the show. NAVC CEO Gene O'Neill echoed that message saying, "VMX is designed to celebrate the continuing work of veterinary professionals worldwide—the people who never stop
More news about: North American Veterinary Community (NAVC)
Jan 20, 2026, 09:47 ET Value Gene Report: Humanoid Robots to Reshape Food Manufacturing Within Six Years as Labor Crisis Deepens
https://youtu.be/SVSWOIVmQDAPodcast Full Deep-Dive: Value Gene Insight Conversations, available on all major podcast platforms.About Value Gene Consulting Group Value Gene Consulting Group is a boutique consulting firm specializing in business solutions for
More news about: Value Gene Consulting Group
Jan 20, 2026, 09:15 ET Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology
companion diagnostic (CDx) to identify adult and pediatric patients with solid tumors who are positive for neurotrophic tyrosine receptor kinase (NTRK) gene fusions and may benefit from treatment with Bayer's VITRAKVI® (larotrectinib). The test is also approved to identify adult patients with locally advanced
More news about: Illumina, Inc.
Jan 20, 2026, 09:00 ET Tanabe Pharma America Announces Positive Topline Results for Dersimelagon in Erythropoietic Protoporphyria (EPP) and X-Linked Protoporphyria (XLP)
enzyme ferrochelatase (FECH), which results from (mutations) in the FECH gene. X-linked protoporphyria (XLP) is a less common type of EPP that results from gain-of-function mutations in the aminolevulinic acid synthase-2 (ALAS2) gene. Both EPP and XLP are characterized by accumulation of protoporphyrin in
More news about: Tanabe Pharma America
Jan 20, 2026, 08:00 ET Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership
Jan. 20, 2026 /PRNewswire/ -- Genezen, a leading gene therapy contract development and manufacturing organization (CDMO), and Atsena Therapeutics ("Atsena"), a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse
More news about: Genezen
Jan 20, 2026, 07:45 ET Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
mipitecan was designed to target FRα across all expression levels with improved therapeutic index. FRα is a cell-surface glycoprotein encoded by the gene FOLR1 that binds to the essential nutrients folic acid and reduced folates, bringing them into cells to facilitate cell division and growth.1,2 FRα is
More news about: Eli Lilly and Company
Jan 20, 2026, 07:00 ET Nanoscope Secures Japan MHLW Sakigake and Orphan Drug Designations Across Inherited Retinal Diseases - A First for a Retinal Gene Therapy
patients with high medical need), the decision establishes a strong regulatory pathway for MCO-010 in Japan. MCO-010 is the first ever retinal gene therapy to be granted both Sakigake and Orphan Drug designations."These designations from Japan's MHLW mark another
More news about: Nanoscope Therapeutics